Proinflammatory and Anti-inflammatory Genes in Stroke Pathogenesis
Citations Over Time
Abstract
The brain's response to ischemic injury is an acute and long-term inflammatory process. This process involves activation of resident cells (mainly microglia, hematogenous macrophages), production of proinflammatory mediators and infiltration of various proinflammatory cells (mainly neutrophils and lymphocytes). These cells play an essential role in ischemic brain tissue by releasing either proinflammatory or anti-inflammatory mediators at different time points. However, the exact pathogenesis of proinflammatory or anti-inflammatory genes in this process has not yet been elucidated. This review aims to investigate the inflammatory process of stroke, especially the role of proinflammatory and anti-inflammatory genes in the pathogenesis of stroke. We also summarize the current clinical trials of drugs that target the inflammatory mechanism for intervention.
Related Papers
- → MicroRNA-345-3p is a potential biomarker and ameliorates rheumatoid arthritis by reducing the release of proinflammatory cytokines(2023)3 cited
- → Dihydrocapsaicin suppresses proinflammatory cytokines expression by enhancing nuclear factor IA in a NF-κB-dependent manner(2016)20 cited
- → Microglia derived from the axotomized adult rat facial nucleus uptake glutamate and metabolize it to glutamine in vitro(2016)6 cited
- Effects of Proinflammatory Cytokines in the Heart(2004)
- Contributions of Microglia in the Healthy and Injured Brain(2015)